Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest - PubMed (original) (raw)

Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest

G G Hicks et al. Mol Cell Biol. 1991 Mar.

Abstract

Overexpression of an activated ras gene in the rat embryo fibroblast line REF52 results in growth arrest at either the G1/S or G2/M boundary of the cell cycle. Both the DNA tumor virus proteins simian virus 40 large T antigen and adenovirus 5 E1a are able to rescue ras induced lethality and cooperate with ras to fully transform REF52 cells. In this report, we present evidence that the wild-type activity of the tumor suppressor gene p53 is involved in the negative growth regulation of this model system. p53 genes encoding either a p53Val-135 or p53Pro-193 mutation express a highly stable p53 protein with a conformation-dependent loss of wild-type activity and the ability to eliminate any endogenous wild-type p53 activity in a dominant negative manner. In cotransfection assays, these mutant p53 genes are able to rescue REF52 cells from ras-induced growth arrest, resulting in established cell lines which express elevated levels of the ras oncoprotein and show morphological transformation. Full transformation, as assayed by tumor formation in nude mice, is found only in the p53Pro-193-plus-ras transfectants. These cells express higher levels of the ras protein than do the p53Val-135-plus-ras-transfected cells. Transfection of REF52 cells with ras alone or a full-length genomic wild-type p53 plus ras results in growth arrest and lethality. Therefore, the selective event for p53 inactivation or loss during tumor progression may be to overcome a cell cycle restriction induced by oncogene overexpression (ras). These results suggest that a normal function of p53 may be to mediate negative growth regulation in response to ras or other proliferative inducing signals.

PubMed Disclaimer

Cited by

The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancer.
Sabbir MG, Prieditis H, Ravinsky E, Mowat MR. Sabbir MG, et al. PLoS One. 2012;7(7):e40302. doi: 10.1371/journal.pone.0040302. Epub 2012 Jul 5. PLoS One. 2012. PMID: 22792269 Free PMC article.
Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.
Lowe SW, Jacks T, Housman DE, Ruley HE. Lowe SW, et al. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2026-30. doi: 10.1073/pnas.91.6.2026. Proc Natl Acad Sci U S A. 1994. PMID: 8134344 Free PMC article.
Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.
Ossovskaya VS, Mazo IA, Chernov MV, Chernova OB, Strezoska Z, Kondratov R, Stark GR, Chumakov PM, Gudkov AV. Ossovskaya VS, et al. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10309-14. doi: 10.1073/pnas.93.19.10309. Proc Natl Acad Sci U S A. 1996. PMID: 8816796 Free PMC article.
c-Fos is required for excision repair of UV-light induced DNA lesions by triggering the re-synthesis of XPF.
Christmann M, Tomicic MT, Origer J, Aasland D, Kaina B. Christmann M, et al. Nucleic Acids Res. 2006;34(22):6530-9. doi: 10.1093/nar/gkl895. Epub 2006 Nov 27. Nucleic Acids Res. 2006. PMID: 17130154 Free PMC article.
Chromosomal instability at a mutational hotspot in polyoma middle T-antigen affects its ability to activate the ARF-p53 tumor suppressor pathway.
Rodriguez-Viciana P, Collins CH, Moule MG, Fried M. Rodriguez-Viciana P, et al. Oncogene. 2006 Mar 9;25(10):1454-62. doi: 10.1038/sj.onc.1209197. Oncogene. 2006. PMID: 16261156

References

1. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7716-9 - PubMed
1. Cell. 1987 Dec 4;51(5):803-12 - PubMed
1. J Virol. 1980 Jun;34(3):752-63 - PubMed
1. J Virol. 1981 Apr;38(1):336-46 - PubMed
1. Virology. 1981 Jul 30;112(2):785-8 - PubMed

Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest - PubMed (original) (raw)